Suppr超能文献

p90核糖体S6激酶-1在奥替普拉诱导CCAAT/增强子结合蛋白-β特异性磷酸化以激活谷胱甘肽S-转移酶A2(GSTA2)基因中的作用。

Role of p90 ribosomal S6-kinase-1 in oltipraz-induced specific phosphorylation of CCAAT/enhancer binding protein-beta for GSTA2 gene transactivation.

作者信息

Lee Seung Jin, Kim Sang Geon

机构信息

National Research Laboratory, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Korea.

出版信息

Mol Pharmacol. 2006 Jan;69(1):385-96. doi: 10.1124/mol.105.018465. Epub 2005 Oct 24.

Abstract

Oltipraz, which has been extensively studied as a cancer chemopreventive agent, promotes phosphatidylinositol 3-kinase-mediated activation of CCAAT/enhancer binding protein-beta (C/EBPbeta). Activated p90 ribosomal S6-kinase-1 (RSK1) phosphorylates major transcription factors, including C/EBPbeta. This study examined whether oltipraz induces phosphorylation of C/EBPbeta at specific residues, and if so, whether RSK1 regulates C/EBPbeta phosphorylation by oltipraz for the GSTA2 gene transactivation. Subcellular fractionation and immunoblot analyses revealed that oltipraz treatment increased the level of C/EBPbeta phosphorylated at Ser(105) in the cytoplasm, which translocated to the nucleus for DNA binding in rat H4IIE cells. Immunoprecipitation-immunoblot, chromatin-immunoprecipitation, and specific mutation analyses revealed that Ser(105)-phosphorylated C/EBPbeta recruited the cAMP response element-binding protein binding protein for histone acetylation and transactivation of the GSTA2 gene. The role of RSK1 in Ser(105)-phosphorylation of C/EBPbeta by oltipraz and its gene transactivation was evidenced by transfection experiments with dominant-negative mutants of RSK1. In mouse Hepa1c1c, human HepG2 cells, and rat primary hepatocytes, oltipraz induced phosphorylation of C/EBPbeta at Thr(217), Thr(266), and Ser(105), respectively, via RSK1. The experiment using small-interference RNA of RSK1 confirmed the essential role of RSK1 in the gene expression. Inhibition of PI3-kinase activity prevented oltipraz-inducible Ser(105)-phosphorylation of rat C/EBPbeta. Oltipraz treatment led to increases in the catalytic activity and nuclear translocation of RSK1, which was abrogated by PI3-kinase inhibition. In summary, oltipraz induces the phosphorylation of rat C/EBPbeta at Ser(105) (functionally analogous Thr(217/266) in mouse and human forms) in hepatocytes, which results in cAMP response element-binding protein-binding protein (CBP) recruitment for the GSTA2 gene transactivation, and the specific C/EBPbeta phosphorylation is mediated by RSK1 downstream of PI3-kinase.

摘要

奥替普拉作为一种癌症化学预防剂已得到广泛研究,它能促进磷脂酰肌醇3激酶介导的CCAAT/增强子结合蛋白β(C/EBPβ)激活。活化的p90核糖体S6激酶1(RSK1)可使包括C/EBPβ在内的主要转录因子磷酸化。本研究检测奥替普拉是否诱导C/EBPβ在特定残基处磷酸化,若如此,RSK1是否通过奥替普拉调节C/EBPβ磷酸化以实现谷胱甘肽S转移酶A2(GSTA2)基因的反式激活。亚细胞分级分离和免疫印迹分析显示,奥替普拉处理可增加大鼠H4IIE细胞胞质中Ser(105)位点磷酸化的C/EBPβ水平,其转位至细胞核进行DNA结合。免疫沉淀-免疫印迹、染色质免疫沉淀及特异性突变分析显示,Ser(105)磷酸化的C/EBPβ募集环磷酸腺苷反应元件结合蛋白结合蛋白以进行组蛋白乙酰化及GSTA2基因的反式激活。用RSK1显性负性突变体进行的转染实验证明了RSK1在奥替普拉诱导的C/EBPβ Ser(105)磷酸化及其基因反式激活中的作用。在小鼠Hepa1c1c、人HepG2细胞及大鼠原代肝细胞中,奥替普拉分别通过RSK1诱导C/EBPβ在Thr(217)、Thr(266)和Ser(105)位点磷酸化。使用RSK1小干扰RNA的实验证实了RSK1在基因表达中的重要作用。抑制PI3激酶活性可阻止奥替普拉诱导的大鼠C/EBPβ Ser(105)磷酸化。奥替普拉处理导致RSK1的催化活性增加及核转位,而PI3激酶抑制可消除这种作用。总之,奥替普拉可诱导肝细胞中大鼠C/EBPβ在Ser(105)(在小鼠和人形式中功能类似的Thr(217/266))位点磷酸化,这导致募集环磷酸腺苷反应元件结合蛋白结合蛋白(CBP)以实现GSTA2基因的反式激活,且特定的C/EBPβ磷酸化由PI3激酶下游的RSK1介导。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验